← All Agilent Technologies, INC filings

Agilent Technologies, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
A
Agilent Technologies, INC
10-K: Agilent Technologies Reports 7% Revenue Growth in FY25
Agilent Technologies achieved 7% net revenue growth in fiscal year 2025, reaching $6.95 billion, driven by strong performance in Life Sciences and Diagnostics Markets, alongside strategic restructuring and share repurchases.
NYSE
A
Agilent Technologies, INC
10-K: Agilent Technologies Reports Fiscal Year 2024 Results Amidst Market Headwinds
Agilent Technologies' fiscal year 2024 saw a 5% revenue decrease, primarily due to reduced customer spending in the pharmaceutical sector, though the Agilent CrossLab business showed growth.